The global Psoriatic Arthritis (PsA) Treatment market size was valued at US$ 8.94 billion in 2024 and is projected to reach US$ 14.67 billion by 2030, at a CAGR of 8.6% during the forecast period 2024-2030.
United States Psoriatic Arthritis (PsA) Treatment market size was valued at US$ 4.12 billion in 2024 and is projected to reach US$ 6.58 billion by 2030, at a CAGR of 8.1% during the forecast period 2024-2030.
Psoriatic Arthritis (PsA) Treatment encompasses various therapeutic approaches, including biologics, DMARDs, NSAIDs, and small molecule drugs, used to manage symptoms and slow disease progression in PsA patients.
Strong market growth supported by increasing disease prevalence and growing awareness. Introduction of novel biologics and targeted therapies driving market value. Emphasis on early diagnosis and treatment initiation expanding the patient pool.
Report Overview
This report provides a deep insight into the global Psoriatic Arthritis (PsA) Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Psoriatic Arthritis (PsA) Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Psoriatic Arthritis (PsA) Treatment market in any manner.
Global Psoriatic Arthritis (PsA) Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Johnson & Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers Squibb
Eli Lilly
Amgen
AstraZeneca
Celgene
Market Segmentation (by Type)
Nonsteriodal Anti-inflammatory Drugs
Disease Modifying Antirheumatic Drugs
Biologics
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Psoriatic Arthritis (PsA) Treatment Market
Overview of the regional outlook of the Psoriatic Arthritis (PsA) Treatment Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Psoriatic Arthritis (PsA) Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Psoriatic Arthritis (PsA) Treatment
1.2 Key Market Segments
1.2.1 Psoriatic Arthritis (PsA) Treatment Segment by Type
1.2.2 Psoriatic Arthritis (PsA) Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Psoriatic Arthritis (PsA) Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Psoriatic Arthritis (PsA) Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Psoriatic Arthritis (PsA) Treatment Market Competitive Landscape
3.1 Global Psoriatic Arthritis (PsA) Treatment Sales by Manufacturers (2019-2024)
3.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Psoriatic Arthritis (PsA) Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Psoriatic Arthritis (PsA) Treatment Sales Sites, Area Served, Product Type
3.6 Psoriatic Arthritis (PsA) Treatment Market Competitive Situation and Trends
3.6.1 Psoriatic Arthritis (PsA) Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Psoriatic Arthritis (PsA) Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Psoriatic Arthritis (PsA) Treatment Industry Chain Analysis
4.1 Psoriatic Arthritis (PsA) Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Psoriatic Arthritis (PsA) Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Psoriatic Arthritis (PsA) Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Type (2019-2024)
6.3 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Psoriatic Arthritis (PsA) Treatment Price by Type (2019-2024)
7 Psoriatic Arthritis (PsA) Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Psoriatic Arthritis (PsA) Treatment Market Sales by Application (2019-2024)
7.3 Global Psoriatic Arthritis (PsA) Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Psoriatic Arthritis (PsA) Treatment Sales Growth Rate by Application (2019-2024)
8 Psoriatic Arthritis (PsA) Treatment Market Segmentation by Region
8.1 Global Psoriatic Arthritis (PsA) Treatment Sales by Region
8.1.1 Global Psoriatic Arthritis (PsA) Treatment Sales by Region
8.1.2 Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Psoriatic Arthritis (PsA) Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Psoriatic Arthritis (PsA) Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Psoriatic Arthritis (PsA) Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Psoriatic Arthritis (PsA) Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Psoriatic Arthritis (PsA) Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Psoriatic Arthritis (PsA) Treatment Basic Information
9.1.2 Pfizer Psoriatic Arthritis (PsA) Treatment Product Overview
9.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Psoriatic Arthritis (PsA) Treatment SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Psoriatic Arthritis (PsA) Treatment Basic Information
9.2.2 Johnson and Johnson Psoriatic Arthritis (PsA) Treatment Product Overview
9.2.3 Johnson and Johnson Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Psoriatic Arthritis (PsA) Treatment SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 AbbVie
9.3.1 AbbVie Psoriatic Arthritis (PsA) Treatment Basic Information
9.3.2 AbbVie Psoriatic Arthritis (PsA) Treatment Product Overview
9.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.3.4 AbbVie Psoriatic Arthritis (PsA) Treatment SWOT Analysis
9.3.5 AbbVie Business Overview
9.3.6 AbbVie Recent Developments
9.4 Novartis
9.4.1 Novartis Psoriatic Arthritis (PsA) Treatment Basic Information
9.4.2 Novartis Psoriatic Arthritis (PsA) Treatment Product Overview
9.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 UCB
9.5.1 UCB Psoriatic Arthritis (PsA) Treatment Basic Information
9.5.2 UCB Psoriatic Arthritis (PsA) Treatment Product Overview
9.5.3 UCB Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.5.4 UCB Business Overview
9.5.5 UCB Recent Developments
9.6 Roche
9.6.1 Roche Psoriatic Arthritis (PsA) Treatment Basic Information
9.6.2 Roche Psoriatic Arthritis (PsA) Treatment Product Overview
9.6.3 Roche Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Bristol-Myers Squibb
9.7.1 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Basic Information
9.7.2 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Overview
9.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.7.4 Bristol-Myers Squibb Business Overview
9.7.5 Bristol-Myers Squibb Recent Developments
9.8 Eli Lilly
9.8.1 Eli Lilly Psoriatic Arthritis (PsA) Treatment Basic Information
9.8.2 Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Overview
9.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.8.4 Eli Lilly Business Overview
9.8.5 Eli Lilly Recent Developments
9.9 Amgen
9.9.1 Amgen Psoriatic Arthritis (PsA) Treatment Basic Information
9.9.2 Amgen Psoriatic Arthritis (PsA) Treatment Product Overview
9.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.9.4 Amgen Business Overview
9.9.5 Amgen Recent Developments
9.10 AstraZeneca
9.10.1 AstraZeneca Psoriatic Arthritis (PsA) Treatment Basic Information
9.10.2 AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Overview
9.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.10.4 AstraZeneca Business Overview
9.10.5 AstraZeneca Recent Developments
9.11 Celgene
9.11.1 Celgene Psoriatic Arthritis (PsA) Treatment Basic Information
9.11.2 Celgene Psoriatic Arthritis (PsA) Treatment Product Overview
9.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Product Market Performance
9.11.4 Celgene Business Overview
9.11.5 Celgene Recent Developments
10 Psoriatic Arthritis (PsA) Treatment Market Forecast by Region
10.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast
10.2 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Region
10.2.4 South America Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Psoriatic Arthritis (PsA) Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Psoriatic Arthritis (PsA) Treatment by Type (2025-2030)
11.1.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Psoriatic Arthritis (PsA) Treatment by Type (2025-2030)
11.2 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Psoriatic Arthritis (PsA) Treatment Sales (K Units) Forecast by Application
11.2.2 Global Psoriatic Arthritis (PsA) Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Psoriatic Arthritis (PsA) Treatment Market Size Comparison by Region (M USD)
Table 5. Global Psoriatic Arthritis (PsA) Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Psoriatic Arthritis (PsA) Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2022)
Table 10. Global Market Psoriatic Arthritis (PsA) Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Psoriatic Arthritis (PsA) Treatment Sales Sites and Area Served
Table 12. Manufacturers Psoriatic Arthritis (PsA) Treatment Product Type
Table 13. Global Psoriatic Arthritis (PsA) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Psoriatic Arthritis (PsA) Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Psoriatic Arthritis (PsA) Treatment Market Challenges
Table 22. Global Psoriatic Arthritis (PsA) Treatment Sales by Type (K Units)
Table 23. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (M USD)
Table 24. Global Psoriatic Arthritis (PsA) Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Psoriatic Arthritis (PsA) Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Psoriatic Arthritis (PsA) Treatment Market Size Share by Type (2019-2024)
Table 28. Global Psoriatic Arthritis (PsA) Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Psoriatic Arthritis (PsA) Treatment Sales (K Units) by Application
Table 30. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application
Table 31. Global Psoriatic Arthritis (PsA) Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Psoriatic Arthritis (PsA) Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application (2019-2024)
Table 35. Global Psoriatic Arthritis (PsA) Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Psoriatic Arthritis (PsA) Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Psoriatic Arthritis (PsA) Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Psoriatic Arthritis (PsA) Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Psoriatic Arthritis (PsA) Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Psoriatic Arthritis (PsA) Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Psoriatic Arthritis (PsA) Treatment Basic Information
Table 44. Pfizer Psoriatic Arthritis (PsA) Treatment Product Overview
Table 45. Pfizer Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Psoriatic Arthritis (PsA) Treatment SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Johnson and Johnson Psoriatic Arthritis (PsA) Treatment Basic Information
Table 50. Johnson and Johnson Psoriatic Arthritis (PsA) Treatment Product Overview
Table 51. Johnson and Johnson Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Psoriatic Arthritis (PsA) Treatment SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. AbbVie Psoriatic Arthritis (PsA) Treatment Basic Information
Table 56. AbbVie Psoriatic Arthritis (PsA) Treatment Product Overview
Table 57. AbbVie Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. AbbVie Psoriatic Arthritis (PsA) Treatment SWOT Analysis
Table 59. AbbVie Business Overview
Table 60. AbbVie Recent Developments
Table 61. Novartis Psoriatic Arthritis (PsA) Treatment Basic Information
Table 62. Novartis Psoriatic Arthritis (PsA) Treatment Product Overview
Table 63. Novartis Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novartis Business Overview
Table 65. Novartis Recent Developments
Table 66. UCB Psoriatic Arthritis (PsA) Treatment Basic Information
Table 67. UCB Psoriatic Arthritis (PsA) Treatment Product Overview
Table 68. UCB Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. UCB Business Overview
Table 70. UCB Recent Developments
Table 71. Roche Psoriatic Arthritis (PsA) Treatment Basic Information
Table 72. Roche Psoriatic Arthritis (PsA) Treatment Product Overview
Table 73. Roche Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Basic Information
Table 77. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Overview
Table 78. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Recent Developments
Table 81. Eli Lilly Psoriatic Arthritis (PsA) Treatment Basic Information
Table 82. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Overview
Table 83. Eli Lilly Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Eli Lilly Business Overview
Table 85. Eli Lilly Recent Developments
Table 86. Amgen Psoriatic Arthritis (PsA) Treatment Basic Information
Table 87. Amgen Psoriatic Arthritis (PsA) Treatment Product Overview
Table 88. Amgen Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Amgen Business Overview
Table 90. Amgen Recent Developments
Table 91. AstraZeneca Psoriatic Arthritis (PsA) Treatment Basic Information
Table 92. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Overview
Table 93. AstraZeneca Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Recent Developments
Table 96. Celgene Psoriatic Arthritis (PsA) Treatment Basic Information
Table 97. Celgene Psoriatic Arthritis (PsA) Treatment Product Overview
Table 98. Celgene Psoriatic Arthritis (PsA) Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Celgene Business Overview
Table 100. Celgene Recent Developments
Table 101. Global Psoriatic Arthritis (PsA) Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Psoriatic Arthritis (PsA) Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Psoriatic Arthritis (PsA) Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Psoriatic Arthritis (PsA) Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Psoriatic Arthritis (PsA) Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Psoriatic Arthritis (PsA) Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Psoriatic Arthritis (PsA) Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Psoriatic Arthritis (PsA) Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Psoriatic Arthritis (PsA) Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Psoriatic Arthritis (PsA) Treatment Market Size (M USD), 2019-2030
Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Psoriatic Arthritis (PsA) Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Psoriatic Arthritis (PsA) Treatment Market Size by Country (M USD)
Figure 11. Psoriatic Arthritis (PsA) Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Manufacturers in 2023
Figure 13. Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Psoriatic Arthritis (PsA) Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type
Figure 18. Sales Market Share of Psoriatic Arthritis (PsA) Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Psoriatic Arthritis (PsA) Treatment by Type in 2023
Figure 20. Market Size Share of Psoriatic Arthritis (PsA) Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Psoriatic Arthritis (PsA) Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application
Figure 24. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application in 2023
Figure 26. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application (2019-2024)
Figure 27. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application in 2023
Figure 28. Global Psoriatic Arthritis (PsA) Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Psoriatic Arthritis (PsA) Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Psoriatic Arthritis (PsA) Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country in 2023
Figure 37. Germany Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Psoriatic Arthritis (PsA) Treatment Sales Market Share by Region in 2023
Figure 44. China Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (K Units)
Figure 50. South America Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Psoriatic Arthritis (PsA) Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Psoriatic Arthritis (PsA) Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Psoriatic Arthritis (PsA) Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Psoriatic Arthritis (PsA) Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Psoriatic Arthritis (PsA) Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Psoriatic Arthritis (PsA) Treatment Market Share Forecast by Application (2025-2030)
